Lawrence M. Sung is a registered patent attorney and partner with Wiley Rein LLP (Washington, DC), where he specializes in biotechnology, pharmaceutical, and medical device patent litigation and counseling. He earned his B.A. in biology from the University of Pennsylvania, his Ph.D. in microbiology from the U.S. Department of Defense, Uniformed Services University, and his J.D. cum laude from the American University, Washington College of Law. Following graduation from law school, Professor Sung served as a judicial clerk to (now Senior) Circuit Judge Raymond C. Clevenger, III, U.S. Court of Appeals for the Federal Circuit (Washington, DC). Dr. Sung also holds academic appointments as a Professor at the Johns Hopkins University Carey Business School and Lecturer at the Catholic University of America Columbus School of Law. He is a former professor and Intellectual Property Law Program Director at the University of Maryland School of Law (Baltimore, MD) and has also taught at the George Washington University Law School, the American University, Washington College of Law, the Northwestern School of Law of Lewis & Clark College, and Seattle University School of Law. He has published extensively in the area of intellectual property law on issues including those concerning biotechnology and technology transfer. He has been recognized as a Washington, DC Best Lawyer® in Biotechnology Law (2013-2017), and was the 2016 Lawyer of the Year in Biotechnology Law in Washington, DC.
Books
Medical Device Patents (2012 ed.).
2011-2012 Patent Law Handbook (2011) (with Jeff E. Schwartz). Abstract
Medical Device Patents (2008 & 2009 Cumulative Supp.). Abstract
The Patent Law Handbook (2003-2009).
Patent Infringement Remedies (2004 & 2005-2009 Cumulative Supps.).
Articles
Medical Alert: Alarming Challenges Facing Medical Technology Innovation, 6 Journal of Business & Technology Law 35 (2011). Abstract
In the Wake of Reinvigorated U.S. Supreme Court Activity in Patent Appeals, 4 Journal of Business & Technology Law 97 (2009). Abstract
The New Private Ordering of Intellectual Property, 4 Journal of Business & Technology Law 1 (2009). Abstract
Future Public Policy and Ethical Issues Facing the Agricultural and Microbial Genomics Sectors of the Biotechnology Industry, 24 Biotechnology Law Report 10 (2005) (with Diane Hoffmann). Abstract
Navigating Uncharted Waters: Intellectual Property Rights Surrounding Genomics Research & Development Information, 6 Journal Of Health Care Law & Policy 194 (2003). Abstract
Piercing the Academic Veil: Disaffecting the Common Law Exception to Patent Infringement Liability and the Future of a Bona Fide Research Use Exemption after Madey v. Duke University, 6 Journal of Health Care Law & Policy 256 (2003) (with Claire M. Maisano). Abstract
The Unblazed Trail: Bioinformatics and the Protection of Genetic Knowledge, 8 Washington University Journal of Law and Policy 261 (2002). Abstract
Stranger in a Strange Land: Biotechnology and the Federal Circuit, 2 Washington University Journal of Law and Policy 167 (2000). Abstract
Collegiality and Collaboration in the Age of Exclusivity, 3 DePaul Journal of Health Care Law 411 (2000).
Echoes of Scientific Truth in the Halls of Justice: The Standards of Review Applied by the United States Court of Appeals for The Federal Circuit in Patent-Related Matters, 48 American University Law Review 1233 (1999).
1995 Patent Law Decisions of the United States Court of Appeals for the Federal Circuit, 45 American University Law Review 1529 (1996).
The Legal Significance of Trade Show Activity Under United States Patent Law, 76 Journal of the Patent and Trademark Office Society 445 (1994) (with Michael D. Kaminski
Comment, Intellectual Property Protection or Protectionism? Declaratory Judgment Use by Patent Owners Against Prospective Infringers. 42 American University Law Review 239 (1992).